NEUROD1 and neoplasm: Gene expression profiling on tumor tissue was previously performed in 15 (47%) patients: ten harbored an inflamed (triple negative, I), three an ASCL1+ (A) and two a neuroendocrine (NEUROD1+, N) molecular profile, as previously reported [17].